You can self-refer or your primary care physician can refer you to one of Scully-Welsh Cancer Center’s medical oncologists. You are encouraged to talk to your doctor about treatment options and we are more than happy to provide the opportunity to present a second opinion in order to achieve the best outcome possible.
James Grichnik, MD, PhD
Dr. James Grichnik is an international expert on the diagnosis and treatment of melanoma and is the Medical Director for the Scully-Welsh Cancer Center. Dr. Grichnik brings extensive knowledge in cancer research and his background includes personalized patient care and the use of genetics and genomics, playing a role in the use of innovative technologies to detect and treat cancer at the earliest, most curable stages. He has directed melanoma programs at the University of Miami and Duke University Medical Center in Durham, North Carolina. Dr. Grichnik’s experience is critical in Indian River County, where cancer is the leading cause of death and melanoma is one of the fastest growing cancers. To make an appointment with Dr. Grichnik, call (772) 226-4800.
Stephen Patterson, MD
Dr. Stephen Patterson is a highly regarded medical oncologist with over 25 years of experience who joined the Scully-Welsh Cancer Center after service at Moffitt Cancer Center and Holy Cross Hospital. Dr. Patterson did his undergraduate work at the University of Notre Dame, earned his medical degree at the University of South Florida, and completed his residency and was fellowship trained at the Moffitt Cancer Center. He was one of the early clinical investigators to study the impact of an immune system modulating agent, anti-PD1, in metastatic lung cancer and melanoma, a therapy that is very promising for patients with metastatic disease. Dr. Patterson specializes in all forms of medical oncology and is continuing to introduce anti-PD1 therapy into the treatment of all approved tumor types here at the Scully-Welsh Cancer Center. To make an appointment with Dr. Patterson, call (772) 226-4810.
Paul G. Pagnini, MD
Paul G. Pagnini, M.D., earned his medical degree at Tufts University School of Medicine in Boston. He completed an internship in medicine and surgery at Newton-Wellesley Hospital in Newton, Massachusetts, and completed his residency in radiation oncology at Tufts/New England Medical Center. Dr. Pagnini was awarded the prestigious Research Fellowship Award from the American Society of Therapeutic Radiation Oncology in his final year of residency. He has advanced training in stereotactic radiosurgery and has performed over 800 Gamma Knife® and CyberKnife® radio-surgical procedures. Before joining the staff at Indian River Medical Center, Dr. Pagnini was an assistant professor at the University of Southern California Keck School of Medicine, where he served as the Radiation Oncology Residency Program Director. He has multiple peer-reviewed publications in the areas of intensity modulated radiation therapy (IMRT), 3D conformal radiotherapy, CyberKnife and Gamma Knife radiosurgery, and is a Diplomat of the American Board of Radiology in Radiation Oncology.
Lilia Correa-Selm, MD
Lilia Correa-Selm, MD, is board certified in dermatology and internal medicine and a fellowship-trained Mohs surgeon with specialized training in confocal microscopy. Dr. Correa-Selm was the chief resident during her dermatology residency at Rutgers-Robert Wood Johnson Medical School, and completed a Mohs and Dermatologic Oncology fellowship at Affiliated Dermatologists and Dermatologic Surgeons at the Morristown Medical Center in Morristown, New Jersey. She performed research at Harvard’s renowned Beth Israel Deaconess Medical Center in Boston, completed her internal medicine residency at Cornell New York Downtown Hospital and performed research at Memorial Sloan Kettering Cancer Center in New York. Dr. Correa-Selm also completed a confocal microscopy fellowship and has performed research in multiple clinical trials involving laser related treatment, cosmeceuticals and body contouring.
Alan Grosset, MD, MSc
Alan Grosset, MD, MSc, earned his medical degree at the University of Glasgow, Scotland. He completed his pathology residency at Westminster Medical School (London) and his internal medicine residency in at Providence Medical Center-Seattle Spokane. He has been a fellow at the University of Utah School of Medicine and is board certified in both medical oncology and in hematology. Before joining Cleveland Clinic Indian River Hospital’s Scully-Welsh Cancer Center, Dr. Grosset held clinical consultant appointments and attachments at North Idaho Cancer Center; University of Wisconsin Cancer Center; Marshfield Clinic; Mayo Clinic Health System; University of Colorado Health System; and Baptist Health Care in Pensacola. His clinical activities include a wide spectrum of hematology and oncology, including targeted and precision individualized medicine.
Alice Ulhoa-Cintra, MD
Alice Ulhoa Cintra, MD, received her medical degree from Drexel University College of Medicine in Philadelphia, Pennsylvania. She completed her residency at Allegheny General Hospital and a fellowship at Western Pennsylvania Hospital in Pittsburgh, and and has a master’s degree in public health. Before joining Cleveland Clinic Indian River Hospital’s Scully-Welsh Cancer Center, Dr. Cintra served patients at ENLOE Specialty Physicians in Chico, California, and Hematology Oncology Associates in Albuquerque, New Mexico. She has been a visiting faculty member at the Mayo Clinic and a guest lecturer at the University of Saint Francis Albuquerque. Dr. Cintra is board certified in both medical oncology and hematology. Her clinical interests include the majority of hematologic and oncologic disorders.
Jonathan Braue, MD
Born and raised in Vero Beach, Jonathan Braue, MD, earned his medical degree from University of South Florida (USF) in Tampa and completed his medical internship and dermatology residency at Vanderbilt University in Nashville, Tennessee. In addition to being an expert in detection and treatment of skin cancer, Dr. Braue also has a passion for treating cutaneous lymphoma. He has presented at the Medical Dermatology Society Annual Meeting in San Diego, the American Society of Plastic Surgeons Meeting in Chicago and the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Task Force meeting in Paris, France. Dr. Braue was a sub-investigator at USF’s Morsani Clinical Research Center for a basal cell carcinoma study, and his work has been published in a number of journals including Blood and JAMA Dermatology.